Identifying common pharmacotherapies associated with reduced COVID-19 morbidity using electronic health records
Victor M Castro, View ORCID ProfileRachel A Ross, Sean M McBride, View ORCID ProfileRoy H Perlis
doi: https://doi.org/10.1101/2020.04.11.20061994
Victor M Castro
1Center for Quantitative Health, Division of Clinical Research, Massachusetts General Hospital, 185 Cambridge Street, Boston, MA, 02114 USA; Victor M Castro, data scientist; Roy H Perlis, director
2Research Information Science and Computing (RISC), Mass General Brigham, 299 Revolution Drive, Suite 775, Somerville, MA, 02145, USA; Victor M Castro, data scientist
Rachel A Ross
3Division of Anxiety and Depressive Disorders, McLean Hospital, 155 Mill Street, Belmont, MA, 02478, USA; Rachel A Ross, staff psychologist and assistant neuroscientist
4Department of Psychiatry, Harvard Medical School, 401 Park Drive, Boston, MA, 02215, USA; Rachel A Ross, instructor; Roy H Perlis, professor
Sean M McBride
5Departments of Genetics and Psychiatry, Perelman School of Medicine, 3400 Civic Center Boulevard, University of Pennsylvania, Philadelphia, PA, 19104, USA; Sean M McBride, assistant professor
Roy H Perlis
1Center for Quantitative Health, Division of Clinical Research, Massachusetts General Hospital, 185 Cambridge Street, Boston, MA, 02114 USA; Victor M Castro, data scientist; Roy H Perlis, director
4Department of Psychiatry, Harvard Medical School, 401 Park Drive, Boston, MA, 02215, USA; Rachel A Ross, instructor; Roy H Perlis, professor
5Departments of Genetics and Psychiatry, Perelman School of Medicine, 3400 Civic Center Boulevard, University of Pennsylvania, Philadelphia, PA, 19104, USA; Sean M McBride, assistant professor
![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Data Availability
Institutional review board approval does not allow sharing of identifiable data outside of the health system, but all analyses are provided as Supplemental Materials.
Posted August 28, 2020.
Identifying common pharmacotherapies associated with reduced COVID-19 morbidity using electronic health records
Victor M Castro, Rachel A Ross, Sean M McBride, Roy H Perlis
medRxiv 2020.04.11.20061994; doi: https://doi.org/10.1101/2020.04.11.20061994
Subject Area
Subject Areas
- Addiction Medicine (347)
- Allergy and Immunology (666)
- Anesthesia (181)
- Cardiovascular Medicine (2637)
- Dermatology (223)
- Emergency Medicine (398)
- Epidemiology (12211)
- Forensic Medicine (10)
- Gastroenterology (758)
- Genetic and Genomic Medicine (4087)
- Geriatric Medicine (387)
- Health Economics (680)
- Health Informatics (2646)
- Health Policy (1003)
- Hematology (362)
- HIV/AIDS (850)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (433)
- Neurology (3862)
- Nursing (209)
- Nutrition (577)
- Oncology (2022)
- Ophthalmology (584)
- Orthopedics (240)
- Otolaryngology (304)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (472)
- Pediatrics (1113)
- Primary Care Research (450)
- Public and Global Health (6516)
- Radiology and Imaging (1398)
- Respiratory Medicine (871)
- Rheumatology (404)
- Sports Medicine (342)
- Surgery (444)
- Toxicology (52)
- Transplantation (185)
- Urology (165)